methylene blue has been researched along with pyrimethamine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fidock, DA; Flannery, EL; Winzeler, EA | 1 |
| Barnard, L; Birkholtz, LM; Botha, M; Brunschwig, C; Burrows, JN; Chibale, K; Churchyard, A; Coetzer, TL; Denti, P; Egan, TJ; Laing, L; Lauterbach, S; Machado, M; Ndubi, F; Njogu, PM; Njoroge, M; Nondaba, S; Okombo, J; Prudêncio, M; Reader, J; Singh, K; Wiesner, L; Wilkinson, C; Wittlin, S; Yeates, C | 1 |
| Adelman, LS; campa, JF; Greenlee, JE; Johnson, WD; Sande, MA | 1 |
| Ziobrowski, S | 1 |
| Maronpot, RR | 1 |
| Armstrong, D; Carey, RM; Kimball, AC; Lieberman, PH | 1 |
| Aldana, I; Bertani, S; Deharo, E; Garavito, G; Quiliano, M; Valentin, A | 1 |
| Kiboi, DM; Mumo, RM; Mwangi, VI; Ng'ang'a, ZW; Omar, SA; Ozwara, HS | 1 |
| Bronzon DA Costa, CM; DE Luca, G; Pereira, LM; Vigato-Ferreira, IC; Yatsuda, AP | 1 |
| Abichabki, NLM; Bronzon da Costa, CM; de Luca, G; Pereira, LM; Yatsuda, AP | 1 |
| Bousema, T; Bradley, J; Brown, JM; Chen, I; Diarra, K; Diawara, H; Dicko, A; Drakeley, C; Gosling, R; Hwang, J; Issiaka, D; Keita, S; Kone, DT; Lanke, K; Mahamar, A; McCulloch, C; Müller, O; Roh, ME; Sanogo, K; Soumare, HM; Srinivasan, V; Stone, WJR; Traore, SF | 1 |
1 review(s) available for methylene blue and pyrimethamine
| Article | Year |
|---|---|
Using genetic methods to define the targets of compounds with antimalarial activity.
Topics: Animals; Anopheles; Antimalarials; Drug Resistance; Genetic Association Studies; Genome, Protozoan; Humans; Malaria, Falciparum; Molecular Targeted Therapy; Plasmodium falciparum | 2013 |
1 trial(s) available for methylene blue and pyrimethamine
| Article | Year |
|---|---|
Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial.
Topics: Adolescent; Adult; Amodiaquine; Artemisinins; Child; Child, Preschool; Drug Combinations; Humans; Malaria, Falciparum; Mali; Methylene Blue; Middle Aged; Plasmodium falciparum; Primaquine; Pyrimethamine; Quinolines; Sulfadoxine; Young Adult | 2018 |
9 other study(ies) available for methylene blue and pyrimethamine
| Article | Year |
|---|---|
Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse Model.
Topics: Animals; Antimalarials; Benzimidazoles; Life Cycle Stages; Malaria; Male; Mice; Plasmodium berghei; Structure-Activity Relationship | 2017 |
Adult toxoplasmosis presenting as polymyositis and cerebellar ataxia.
Topics: Antigens; Biopsy; Cerebellar Ataxia; Complement Fixation Tests; Creatine Kinase; Gold Colloid, Radioactive; Humans; Leucovorin; Lymphocyte Activation; Lymphocytes; Male; Methylene Blue; Middle Aged; Mitogens; Muscles; Myositis; Pyrimethamine; Recurrence; Serologic Tests; Sulfadiazine; Toxoplasmosis | 1975 |
[Effect of treatment on the Sabin-Feldman test in ocular toxoplasmosis].
Topics: Child; Chorioretinitis; Coccidiostats; Drug Therapy, Combination; Follow-Up Studies; Humans; Leucomycins; Methylene Blue; Pyrimethamine; Serologic Tests; Toxoplasmosis, Ocular; Uveitis | 1985 |
Erythrocyte glucose-6-phosphate dehydrogenase and glutathione deficiency in sheep.
Topics: Age Factors; Animals; Chromium Isotopes; Disease Models, Animal; Erythrocytes; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Hemolysis; Male; Methylene Blue; Nitrofurantoin; Primaquine; Pyrimethamine; Sex Factors; Sheep | 1972 |
Toxoplasmosis. Clinical experiences in a cancer hospital.
Topics: Adolescent; Adult; Aged; Child; Complement Fixation Tests; Diagnosis, Differential; Female; Hodgkin Disease; Humans; Immunosuppression Therapy; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymph Nodes; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methylene Blue; Middle Aged; Myeloproliferative Disorders; Neuroblastoma; Pyrimethamine; Serologic Tests; Sulfonamides; Toxoplasmosis | 1973 |
The in vivo antimalarial activity of methylene blue combined with pyrimethamine, chloroquine and quinine.
Topics: Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Therapy, Combination; Enzyme Inhibitors; Malaria; Male; Methylene Blue; Mice; Plasmodium berghei; Pyrimethamine; Quinine | 2012 |
Methylene blue inhibits lumefantrine-resistant Plasmodium berghei.
Topics: Animals; Antimalarials; Disease Models, Animal; Drug Resistance; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Ethanolamines; Female; Fluorenes; Lumefantrine; Malaria; Male; Methylene Blue; Mice; Parasitemia; Plasmodium berghei; Pyrimethamine; Survival Analysis; Treatment Outcome | 2016 |
Evaluation of methylene blue, pyrimethamine and its combination on an in vitro Neospora caninum model.
Topics: Animals; Antimalarials; Chlorocebus aethiops; Coccidiosis; Enzyme Inhibitors; Inhibitory Concentration 50; Methylene Blue; Neospora; Pyrimethamine; Vero Cells | 2017 |
Synergic in vitro combinations of artemisinin, pyrimethamine and methylene blue against Neospora caninum.
Topics: Animals; Antimalarials; Artemisinins; Chlorocebus aethiops; Coccidiosis; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Methylene Blue; Neospora; Pyrimethamine; Vero Cells | 2018 |